Molecular Point Of Care Testing (Using NAAT) Market Competitive Strategies & Market Analysis by 2029
Description
The other
factors, such as the lack of skilled professionals and the high cost of
customized molecular point-of-care testing (using NAAT), hamper the growth of
the global molecular end-of-care testing (using NAAT) market. On the other
hand, the increased healthcare expenditure and emerging countries with
developed hospitals act as an opportunity to grow the global molecular point of
care testing (using NAAT) market. molecular
point of care testing (using NAAT) market is expected to
reach USD 62,553.67 million by 2029 , from USD 25,170.05 million in 2020,
growing at the CAGR of 10.8% in the forecast period of 2021 to 2029 . The
global molecular point of care testing (using NAAT) market is expected to grow
due to improving healthcare facilities and infrastructures and the adoption of
end-of-care testing at the hospital, laboratories, and clinics, which can drive
the market's growth. The other factors anticipated to propel the development of
the molecular point of care testing (using NAAT) market include the rising
prevalence of infectious diseases.
Molecular Point of Care Testing (using NAAT) Market
Analysis and Insights
These
instruments are essentially used in molecularly detecting various disorders
such as HIV, HPV, and respiratory disease through NAAT technology.
NAAT is Nucleic Acid Amplification Techniques that allow the identification of
pathogenic organisms by detecting their DNA or RNA. The leading
MOLECULAR POINT OF CARE TESTING (USING NAAT) market report eases the process of
acquiring valuable market insights with the new skills, latest tools and
innovative programs, which is sure to aid in achieving business goals. POCT is
characterized as testing which can be done close to the patient where a medical
decision can be made immediately, including the results and monitoring. POCT
devices now entering clinical use are based on nucleic acid amplification
technologies (NAAT), defined here as second-generation devices. These platforms
generally have improved sensitivity, typically 60 to 90%, compared to
first-generation POCTs, and require portable instrumentation with a footprint
of approximately 30cm x 30cm.
Request Access for Molecular Point Of Care
Testing (Using NAAT) Market
Sample Report:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=-molecular-point-of-care-testing-using-naat-market
Molecular Point Of Care
Testing (Using NAAT) Market Scope And Market Size
With the increase in the successful diagnosis of
chronic diseases, including cancer, anemia, type 2 diabetes, and others, the
improved health care professionals provide regular training sessions for the
professionals for conducting tests in account for the improvement of diagnosis
rate in the region. With the increase in the burden of diseases, the diagnosis
rate is also increasing. With the advancements in the diagnosis, the rate is
also growing for people going through the diagnosis.
- On the basis of product, the molecular point
of care testing (using NAAT) market is segmented into instruments,
consumables, and reagents. In 2021, the consumables & reagents segment
in the molecular point of care testing (using NAAT) market is expected to
grow due to changing lifestyles and increasing chronic diseases, and
increasing awareness of over-the-counter NAAT-based POCT devices.
- On the basis of end user, the molecular point
of care testing (using NAAT) market is segmented into laboratories,
hospitals, clinics, ambulatory centres, home care, assisted living
facilities, and others. In 2021, the laboratories segment in the molecular
point of care testing (using NAAT) market is expected to dominate because
of the high preference of POCT testing being recommended to laboratories
as they are fully focused on the diagnosis of the various disorder.
- On the basis of distribution channel, the
molecular point of care testing (using NAAT) market is segmented into
direct tender, third party distributor, online sales. In 2021, the direct
sales segment in the molecular point of care testing (using NAAT) market
is expected to grow due to the increased demand for advanced technologies
and testing requirements in medical care for operations and diagnosis.
Get TOC of the Report:
https://www.databridgemarketresearch.com/toc/?dbmr=-molecular-point-of-care-testing-using-naat-market
Major TOC of the Molecular
Point Of Care Testing (Using NAAT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Access Full Report:- https://www.databridgemarketresearch.com/reports/-molecular-point-of-care-testing-using-naat-market
Molecular Point Of Care Testing (Using NAAT) Market Country Level
Analysis
Data points such as new sales,
replacement sales, country demographics, regulatory acts, and import-export
tariffs are some of the major pointers used to forecast the market scenario for
individual countries. Also, the presence and availability of brands and their
challenges faced due to large or scarce competition from local and domestic
brands, the impact of sales channels are considered while providing forecast
analysis of the country data.
Competitive Landscape and Molecular Point Of Care Testing (Using
NAAT) Market Share Analysis
Point-of-care testing devices are beneficial for
detecting various diseases and supporting treatment plans using POC software
and solutions. Healthcare spending comprises out-of-pocket payments (people
paying for their care), government expenditure, and sources including health
insurance and activities by non-governmental organizations. Increasing
healthcare expenditure and infrastructure can help patients take hassle-free
advanced treatment to receive better diagnoses, procedures, and treatment for
fast recovery. U.S. is expected to dominate
the molecular point of care testing (using NAAT) market because of the
increasing diagnosis rate and awareness about chronic disease. U.K. is expected
to molecular point of care testing (using NAAT) market due to increased
procurement of advanced technologies available for molecular POCT. India in
South Asia region is expected to
molecular point of care testing (using NAAT) market due to the presence
of huge potential for procurement of product and rising healthcare.
Some of the major companies providing molecular point of care testing
(using NAAT) products in the molecular
point of care testing (using NAAT) market are
·
Thermo Fisher Scientific Inc.,
·
Hologic, Inc.,
·
BD, F. Hoffmann-La Roche Ltd,
·
binx health, inc.,
·
Sysmex (A Subsidiary of Sysmex
Corporation),
·
Co-Diagnostics, Inc.,
·
ABBOTT, Seegene Inc.,
·
bioMérieux SA,
·
QIAGEN,
·
Bio-Rad Laboratories, Inc.,
·
PerkinElmer Inc.,
·
Grifols,
·
S.A.,
·
Quidel Corporation,
·
GenMark Diagnostics, Inc.,
·
SD Biosensor, INC.,
·
Oxford Nanopore Technologies,
·
Wondfo,
·
Randox Laboratories Ltd.,
·
Meridian Bioscience,
·
Sekisui Diagnostics,
·
QuantuMDx Group Ltd.,
·
Lucira Health Inc.,
·
Danaher,
Browse Related Reports @
Global
Molecular Point Of Care Testing (Using NAAT) Market
Global
Smart Contact Lens Market
Asia-Pacific Single Use Medical Devices Reprocessing Market
Middle East and Africa Single Use Medical Devices Reprocessing
Market
North America Single Use Medical Devices Reprocessing Market
Global Electronic Clinical Outcome Assessment (eCOA) for Content
Licensed Market
Europe Electronic Clinical Outcome Assessment (eCOA) for Content
Licensed Market
About Us:
Data Bridge Market Research set forth itself as an unconventional
and neoteric Market research and consulting firm with unparalleled level of
resilience and integrated approaches. We are determined to unearth the best
market opportunities and foster efficient information for your business to
thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comments
Post a Comment